Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Terminated 2Not yet recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Endocrine 3Genitourinary 1

Conditions

Adrenal Gland Neoplasms 2Urinary Bladder Neoplasms 1Pheochromocytoma 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Adrenalectomy × Clear all
NCT06062082 2025-02-13

HEMODADRE

Central Hospital, Nancy, France

Completed
60 enrolled
Endocrine

Pheochromocytoma

NCT05888753 2023-06-22

Textbook Outcome in Adrenal Neoplasms

Hospital General Universitario de Alicante

Completed
105 enrolled
Endocrine

Adrenal Gland Neoplasms

NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

The Affiliated Hospital of Qingdao University

Phase NA Completed
1 enrolled
EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡